Skip to main content
. 2012 Apr 4;14(6):689–700. doi: 10.1093/neuonc/nos074

Fig. 2.

Fig. 2.

Detection of miRNAs of miR-200 family in metastatic brain cancer patients. (A) MiR-200b expression levels were examined by qRT-PCR in various primary and metastatic brain tumor tissue specimens and normalized to miR-24, as described in Materials and Methods. Error bars indicate standard errors between technical duplicates. PNET = primitive neuroectodermal brain tumor. MiR-200a (B), miR-200b (C), miR-200c (D), and miR-141 (E) levels were examined by qRT-PCR in the CSF samples of neurological patients. MiRNA levels are normalized to miR-24 and demonstrated for individual patients. There are 9 samples with undetectable miR-200 levels (values = 0) present in the GBM group. Horizontal lines indicate arithmetic mean for each group of samples. Differences between group means that reached statistical significance, as determined by a nonparametric Wilcoxon signed rank test, are indicated with asterisks: *P < .05, **P < .001, ***P < .0001. Corresponding values normalized to miR-125b are presented in Supplementary Fig. S2C–F. (F) The average levels of miR-200a/miR-200b and miR-141/miR-200c cluster miRNAs in CSF of metastatic brain cancer patients. The error bars represent the standard error of the mean for each group of patients.